Fabre-Kramer Pharmaceuticals
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5847 San Felipe St Ste 2000, Houston, Te...Phone Number
(713) 975-6900Website
www.fabrekramer.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Fabre-Kramer Pharmaceuticals
Fabre-Kramer Pharmaceuticals, Inc. specializes in the identification, development, and commercialization of psychotropic drugs aimed at treating psychiatric and neurologic disorders. The company is currently focused on the commercial launch of its lead product, Gepirone Hydrochloride. Their intended clients include healthcare providers and patients in need of psychiatric and neurologic treatments. Fabre-Kramer is recognized as a leader in the pharmaceutical industry for its innovative approaches to mental health care.Explore more
Fabre-Kramer Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fabre-Kramer Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Fabre-Kramer Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Fabre-Kramer Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Fabre-Kramer Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Fabre-Kramer Pharmaceuticals
Click to see if Fabre-Kramer Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Fabre-Kramer Pharmaceuticals launches new products
Check out if Fabre-Kramer Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Fabre-Kramer Pharmaceuticals has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Fabre-Kramer Pharmaceuticals
Compare insights from companies similar to Fabre-Kramer Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Fabre-Kramer Pharmaceutic...
<$5M
1-10
Private
-
1992
JS
Jennifer SpringDirector, Global Commercial Operations
Company Profile Activity
Activity Insights
Fabre-Kramer Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Fabre-Kramer Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fabre-Kramer Pharmaceuticals.
Fabre-Kramer Pharmaceuticals Tech Stack
A closer look at the technologies used by Fabre-Kramer Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fabre-Kramer Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Fabre-Kramer Pharmaceuticals, Inc. specializes in the identification, development, and commercialization of psychotropic drugs aimed at treating psychiatric and neurologic disorders. The company is currently focused on the commercial launch of its lead product, Gepirone Hydrochloride. Their intended clients include healthcare providers and patients... Read More
